CVC weighs $2bn sale of Dr Teal’s owner Arthea
Thursday, September 10, 2026 · first reported by Private Equity Wire
CVC Capital Partners exploring $2bn sale of Arthea (Dr Teal's, Bodycology, Cantu), acquired for $1.43bn in 2017; Moelis and William Blair advising on potential exit from personal care portfolio.
- Also named
- Moelis, William Blair
- Deal value
- $2B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on CVC Capital Partners
Everything on this firm →- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets